Systemic adjuvant therapy in mammographically discovered invasive cancer.
Most mammographically discovered invasive breast cancers are 1 cm or smaller in diameter. These cancers have such a favorable prognosis that systemic therapy may be inappropriate. Special histologies, micrometastatic deposits in axiliary lymph nodes, and lesions of borderline size all pose special problems of interpretation relative to the role of systemic therapy.